Press release

Galibra Neuroscience Receives FDA Orphan Drug and Rare Pediatric Disease Designations for SSADH Deficiency Gene Therapy

Dual designations support development of a potential first disease-modifying therapy for an ultra-rare neurometabolic disorder BOSTON, Aug. 5, 2026 /PRNewswire/…

Read More »

AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, as Preclinical Candidate (PCC) for Ocular Diseases, Inflammatory Disorders and Aging

As a dual-purpose, potential first-in-class, “pipeline-in-a-drug” candidate, ISM9077 provides an innovative solution for ocular diseases, inflammatory disorders, and the fundamental…

Read More »

Infor Appoints Yuka Kanemitsu as President and Representative Director of Infor Japan to Accelerate Industry Cloud Growth and AI-Driven Business Transformation

Experienced technology executive to lead Infor’s next phase of growth in Japan, helping customers modernize operations through industry-specific cloud solutions,…

Read More »

Menu-Order AI Names Dr. Leigh-Anne Dale as Founding Medical Advisor

Physician specializing in Transplant Nephrology, will support educational initiatives for GLP-1 users, physicians and clinicians. BOSTON, Aug. 5, 2026 /PRNewswire/…

Read More »

Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China

SAN FRANCISCO and SUZHOU, China, Aug. 5, 2026 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company…

Read More »